Developing next gen therapeutics for rheumatology & autoimmune diseases

 
edited.jpg

Dianomi Therapeutics is a development stage biopharmaceutical company advancing a pipeline of next generation treatments targeting rheumatology & autoimmune diseases. Our proprietary Mineral Coated Microparticle (MCM) technology is designed to provide proven drugs with sustained release delivery for improved stability, safety and efficacy.